Trials / Completed
CompletedNCT03382873
Augmented Care at Worksite for Diabetes Prevention
Impact of Augmented Care at the Worksite for Diabetes Prevention
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study was to evaluate the impact of augmented care at the worksite through a lifestyle intervention for diabetes prevention among employees with prediabetes who were slower to respond to a standard diabetes prevention intervention.
Detailed description
Employees at the Ohio State University (OSU) with prediabetes participated in a standard lifestyle intervention (Group Lifestyle Balance) for diabetes prevention. Participants who did not achieve \>2.5% weight loss at week 5 of the intervention were stratified to the augmented intervention (Group Lifestyle Balance Plus) at week 5. The impact of the augmented intervention compared to the standard intervention was determined at 4, 12 and 18 months from baseline to determine if implementing early enhanced training helped participants achieve and maintain weight loss similar to those who received the standard intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Group Lifestyle Balance (GLB) | The intervention included the following key features: group-based sessions led by a lifestyle coach; a structured, state-of-the-art, 16-session core-curriculum that emphasized behavioral self-management strategies for weight loss and physical activity; 8-months of extended care with bimonthly or monthly sessions; self-monitoring of diet and physical activity. |
| BEHAVIORAL | Group Lifestyle Balance Plus (GLB+) | The GLB+ intervention arm included participants who did not achieve the targeted percent weight loss by week 5 and incorporated enhanced training in values clarification, mindful decision making, planning, and problem solving. GLB+ included the same number of group-based sessions as GLB. |
Timeline
- Start date
- 2018-02-08
- Primary completion
- 2022-04-15
- Completion
- 2022-04-15
- First posted
- 2017-12-26
- Last updated
- 2024-04-11
- Results posted
- 2024-04-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03382873. Inclusion in this directory is not an endorsement.